Level Four Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-576
| Closed | -$474K | – | 837 |
|
|
2023
Q3 | $474K | Buy |
576
+100
| +21% | +$82.3K | 0.03% | 452 |
|
|
2023
Q2 | $342K | Buy |
476
+205
| +76% | +$147K | 0.02% | 586 |
|
|
2023
Q1 | $223K | Sell |
271
-24
| -8% | -$19.7K | 0.01% | 661 |
|
|
2022
Q4 | $213K | Buy |
295
+3
| +1% | +$2.16K | 0.02% | 599 |
|
|
2022
Q3 | $201K | Sell |
292
-65
| -18% | -$44.7K | 0.02% | 511 |
|
|
2022
Q2 | $211K | Sell |
357
-135
| -27% | -$79.8K | 0.02% | 512 |
|
|
2022
Q1 | $344K | Buy |
492
+120
| +32% | +$83.9K | 0.03% | 484 |
|
|
2021
Q4 | $235K | Buy |
+372
| New | +$235K | 0.02% | 568 |
|
|
2021
Q3 | – | Sell |
-3,670
| Closed | -$2.05M | – | 601 |
|
|
2021
Q2 | $2.05M | Buy |
+3,670
| New | +$2.05M | 0.14% | 165 |
|